MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-03-2025
Boston Scientific Corporation Total Shareholders Equity 2011-2026 | BSX
Annual Total Shareholders Equity Boston Scientific Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.8 B | 19.3 B | 17.6 B | 16.6 B | 15.3 B | 13.9 B | 8.73 B | 7.01 B | 6.73 B | 6.32 B | 6.46 B | 6.54 B | 6.87 B | 11.4 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 21.8 B | 6.32 B | 11.7 B |
Quarterly Total Shareholders Equity Boston Scientific Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.4 B | 22.4 B | 22.2 B | 20.7 B | 20.4 B | 20.2 B | 18.9 B | 18.2 B | 17.8 B | 17.6 B | 17.6 B | 17.3 B | 16.7 B | 16.6 B | 16.5 B | 15.9 B | 15.7 B | 15.3 B | 15.3 B | 15.3 B | 15.3 B | 13.9 B | 13.9 B | 13.9 B | 13.9 B | 8.73 B | 8.73 B | 8.73 B | 8.73 B | 7.01 B | 7.01 B | 7.01 B | 7.01 B | 6.73 B | 6.73 B | 6.73 B | 6.73 B | 6.32 B | 6.32 B | 6.32 B | 6.32 B | 6.46 B | 6.46 B | 6.46 B | 6.46 B | 6.54 B | 6.54 B | 6.54 B | 6.54 B | 6.87 B | 6.87 B | 6.87 B | 6.87 B | 11.4 B | 11.4 B | 11.4 B | 11.4 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 23.4 B | 6.32 B | 11.8 B |
Total Shareholders Equity of other stocks in the Medical devices industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
104 M | $ 31.63 | 2.03 % | $ 1.4 B |  USA |
 |
Acutus Medical
AFIB
|
-879 K | - | -26.83 % | $ 2.62 M | USA |
 |
Abiomed
ABMD
|
1.33 B | - | - | $ 17.2 B | USA |
 |
Allied Healthcare Products
AHPI
|
5.23 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
-14.2 M | $ 21.25 | 2.36 % | $ 3.04 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
26.7 M | $ 3.6 | 2.86 % | $ 125 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
198 M | $ 9.15 | 2.81 % | $ 657 M |  Israel |
 |
Bio-Rad Laboratories
BIO
|
6.57 B | $ 320.95 | 5.1 % | $ 9.06 B | USA |
 |
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
963 M | $ 42.12 | 3.97 % | $ 1.3 B | USA |
 |
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | USA |
 |
BioSig Technologies
BSGM
|
-1.54 M | - | 37.08 % | $ 85.7 M | USA |
 |
Bruker Corporation
BRKR
|
1.78 B | $ 50.6 | 5.18 % | $ 7.54 K | USA |
 |
EDAP TMS S.A.
EDAP
|
40.9 M | $ 3.48 | 2.35 % | $ 130 M |  France |
 |
Abbott Laboratories
ABT
|
47.7 B | $ 126.37 | 1.76 % | $ 220 B | USA |
 |
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-172 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
43.2 M | $ 28.03 | 2.34 % | $ 237 M | USA |
 |
Second Sight Medical Products
EYES
|
17.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Neovasc
NVCN
|
1.98 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | USA |
 |
InMode Ltd.
INMD
|
704 M | $ 15.27 | 3.18 % | $ 1.21 B | Israel |
 |
IRadimed Corporation
IRMD
|
86.8 M | $ 98.11 | 2.73 % | $ 1.24 B | USA |
 |
Align Technology
ALGN
|
3.85 B | $ 160.18 | 2.66 % | $ 12 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
355 M | $ 18.13 | 3.22 % | $ 418 M | USA |
 |
Accuray Incorporated
ARAY
|
81.2 M | $ 0.89 | 4.38 % | $ 91.5 M | USA |
 |
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
25.4 M | $ 14.34 | 2.21 % | $ 388 M | USA |
 |
FONAR Corporation
FONR
|
150 M | $ 18.52 | 0.03 % | $ 121 M | USA |
 |
LivaNova PLC
LIVN
|
1.32 B | $ 63.29 | 4.37 % | $ 3.43 B |  Britain |
|
LENSAR
LNSR
|
4.86 M | $ 11.32 | -2.5 % | $ 130 M | USA |
 |
GBS
GBS
|
3 M | - | -0.57 % | $ 7.12 M | USA |
 |
IRIDEX Corporation
IRIX
|
9.52 M | $ 1.21 | 3.42 % | $ 19.5 M | USA |
 |
Globus Medical
GMED
|
4.18 B | $ 90.81 | 4.02 % | $ 12.3 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.55 B | $ 12.56 | 4.58 % | $ 967 M | USA |
 |
Aziyo Biologics
AZYO
|
-38.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
Establishment Labs Holdings
ESTA
|
53.1 M | $ 65.25 | -5.21 % | $ 1.84 B |  Costa-rica |